Copyright
©The Author(s) 2025.
World J Exp Med. Jun 20, 2025; 15(2): 102897
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.102897
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.102897
Table 1 Body weight of nude mice treated with GO-Y030, mean ± SD
| Body weight (g) | Day 1 | Day 3 | Day 6 | P value |
| Control | 21.98 ± 1.30 | 24.98 ± 1.10 | 24.24 ± 1.22 | 0.55 |
| GO-Y030 (1 mg/kg, ip) | 23.7 ± 1.97 | 24.92 ± 0.92 | 24.2 ± 0.84 | |
| GO-Y030 (2 mg/kg, ip) | 22.04 ± 1.52 | 25.02 ± 1.24 | 24.42 ± 1.18 |
Table 2 In vivo distribution of GO-Y030
| Times after administration (hour) | 1 | 3 | 6 |
| Blood concentration (ng/mL) | 18.0 | 46.7 | 58.2 |
| Brain distribution (pg/mg tissue) | 0 | 26.8 | 23.1 |
- Citation: Terasawa A, Shimazu K, Nanjo H, Miura M, Shibata H. Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models. World J Exp Med 2025; 15(2): 102897
- URL: https://www.wjgnet.com/2220-315x/full/v15/i2/102897.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i2.102897